Analysts have provided fresh ratings for several healthcare companies. Integer Holdings received a reiterated Buy rating from Truist Financial, while Spyre Therapeutics also maintained a Buy rating from Mizuho Securities. Tandem Diabetes Care saw Mizuho Securities maintain a Hold rating, despite a recent upgrade to Hold from Bank of America Securities.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Spyre Therapeutics (SYRE) and Tandem Diabetes Care (TNDM)
Analysts have provided fresh ratings for several healthcare companies. Integer Holdings received a reiterated Buy rating from Truist Financial, while Spyre Therapeutics also maintained a Buy rating from Mizuho Securities. Tandem Diabetes Care saw Mizuho Securities maintain a Hold rating, despite a recent upgrade to Hold from Bank of America Securities.